Correlation Between Tekla Healthcare and Ubs Us

Can any of the company-specific risk be diversified away by investing in both Tekla Healthcare and Ubs Us at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tekla Healthcare and Ubs Us into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Tekla Healthcare Opportunities and Ubs Dividend Ruler, you can compare the effects of market volatilities on Tekla Healthcare and Ubs Us and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tekla Healthcare with a short position of Ubs Us. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tekla Healthcare and Ubs Us.

Diversification Opportunities for Tekla Healthcare and Ubs Us

0.27

Correlation Coefficient

Tekla Healthcare  Ubs Us

Modest diversification

The 3 months correlation between Tekla and Ubs is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding Tekla Healthcare Opportunities and Ubs Dividend Ruler in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ubs Dividend Ruler and Tekla Healthcare is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tekla Healthcare Opportunities are associated (or correlated) with Ubs Us. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ubs Dividend Ruler has no effect on the direction of Tekla Healthcare i.e., Tekla Healthcare and Ubs Us go up and down completely randomly.

Pair Corralation between Tekla Healthcare and Ubs Us

Considering the 90-day investment horizon Tekla Healthcare Opportunities is expected to generate 1.12 times more return on investment than Ubs Us. However, Tekla Healthcare is 1.12 times more volatile than Ubs Dividend Ruler. It trades about 0.14 of its potential returns per unit of risk. Ubs Dividend Ruler is currently generating about -0.04 per unit of risk. If you would invest  1,862  in Tekla Healthcare Opportunities on December 27, 2024 and sell it today you would earn a total of  164.00  from holding Tekla Healthcare Opportunities or generate 8.81% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Tekla Healthcare Opportunities  vs.  Ubs Dividend Ruler

Tekla Healthcare Opp

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Tekla Healthcare Opportunities are ranked lower than 11 (%) of all funds and portfolios of funds over the last 90 days. Even with relatively inconsistent technical indicators, Tekla Healthcare may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Ubs Dividend Ruler

Risk-Adjusted Performance

Very Weak

Over the last 90 days Ubs Dividend Ruler has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Ubs Us is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Tekla Healthcare and Ubs Us

The main advantage of trading using opposite Tekla Healthcare and Ubs Us positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tekla Healthcare position performs unexpectedly, Ubs Us can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ubs Us will offset losses from the drop in Ubs Us' long position.

The idea behind Tekla Healthcare Opportunities and Ubs Dividend Ruler pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.